Involvement of the lymphatic system in salt-sensitive hypertension in humans

Medical Science Monitor

Volumn 17, Issue 10, 2011, Pages

  Liu, Fuqiang ^a   Mu, Jianjun ^a   Yuan, Zuyi ^a   Lian, Qiufang ^a   Zheng, Shuhui ^a   Wu, Guanji ^a   Liu, Enqi ^b,c  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Diet intervention; Lymphatic system; Salt sensitive; Vascular endothelial growth factor C

Indexed keywords

BIOLOGICAL MARKER; VASCULOTROPIN C;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CHINA; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; HYPOTHESIS; LYMPHATIC SYSTEM; MALE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SALT INTAKE; SALT SENSITIVE HYPERTENSION; SODIUM RESTRICTION;

EID: 80054040656     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.881978     Document Type: Article

References (22)

1. Muntzel M, Drüeke T: A comprehensive review of the salt and blood pressure relationship. Am J Hypertens, 1992; 5: 1S-42S
2. Weinberger MH: Salt sensitivity of blood pressure in humans. Hypertension, 1996; 27: 481-90
3. Adrogue HJ, Madias NE: Sodium and potassium in the pathogenesis of hypertension. N Engl J Med, 2007; 356(19): 1966-78
4. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M: Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension, 2001; 37: 429-32
5. Morimoto A, Uzu T, Fujii T et al: Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet, 1997; 350: 1734-37
6. Jeltsch M, Kaipainen A, Joukov V et al: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science, 1997; 276(5317): 1423-25
7. Machnik A, Dahlmann A, Kopp C et al: Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats. Hypertension, 2010; 55(3): 755-61
8. Fang Y, Mu JJ, He LC et al: Salt loading on plasma asymmetrical dimeth-ylarginine and the protective role of potassium supplement in normo-tensive salt-sensitive asians. Hypertension, 2006; 48: 724-29
9. Wright JT, Rahman M, Scarpa A et al: Determinants of salt sensitivity in black and white normotensive and hypertensive women. Hypertension, 2003; 42: 1087-92
10. Titze J: Water-free sodium accumulation. Semin Dial, 2009; 22(3): 253-55
11. Titze J, Machnik A: Sodium sensing in the interstitium and relationship to hypertension. Curr Opin Nephrol Hypertens, 2010; 19(4): 385-92
12. Titze J, Shakibaei M, Schaffhuber M et al: Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin. Am J Physiol Heart Circ Physiol, 2004; 287(1): H203-8
13. Titze J, Lang R, Ilies C et al: Osmotically inactive skin Na+ storage in rats. Am J Physiol Renal Physiol, 2003; 285(6): F1108-17
14. Marvar PJ, Gordon FJ, Harrison DG: Blood pressure control: salt gets under your skin. Nat Med, 2009; 15(5): 487-88
15. Rabelink TJ, Rotmans JI: Salt is getting under our skin. Nephrology Dialysis Transplantation, 2009; 24(11): 3282-83
16. Mandriota SJ, Jussila L, Jeltsch M et al: Vascular endothelial growth fac-tor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J, 2001; 20(4): 672-82
17. Karpanen T, Egeblad M, Karkkainen MJ et al: Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphat-ic tumor growth. Cancer Res, 2001; 61(5): 1786-90
18. Yoo SY, Lee SY, Yoo NC: Cytokine expression and cancer detection. Med Sci Monit, 2009; 15(3): RA49-56
19. Machnik A, Neuhofer W, Jantsch J et al: Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C - dependent buffering mechanism. Nature Medicine, 2009; 15(5): 545-52
20. Titze J, Luft FC, Bauer K et al: Extrarenal Na+ balance, volume, and blood pressure homeostasis in intact and ovariectomized deoxycorti-costerone-acetate salt rats. Hypertension, 2006; 47(6): 1101-17
21. Wu S, Chen JJ, Kudelka A et al: Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis. Lancet Oncol, 2008; 9(2): 117-23
22. Yeh E, Bickford CL: Cardiovascular Complications of Cancer Therapy: Incidence, Pathogenesis, Diagnosis, and Management. J Am Coll Cardiol, 2009; 53(24): 2231-47